279 related articles for article (PubMed ID: 25477880)
1. Metabolic regulation of regulatory T cell development and function.
Coe DJ; Kishore M; Marelli-Berg F
Front Immunol; 2014; 5():590. PubMed ID: 25477880
[TBL] [Abstract][Full Text] [Related]
2. Metabolic regulation of T lymphocytes.
MacIver NJ; Michalek RD; Rathmell JC
Annu Rev Immunol; 2013; 31():259-83. PubMed ID: 23298210
[TBL] [Abstract][Full Text] [Related]
3. Metabolic fuelling of proper T cell functions.
Matarese G; Colamatteo A; De Rosa V
Immunol Lett; 2014 Oct; 161(2):174-8. PubMed ID: 24365064
[TBL] [Abstract][Full Text] [Related]
4. Metabolic pathways in T cell activation and lineage differentiation.
Almeida L; Lochner M; Berod L; Sparwasser T
Semin Immunol; 2016 Oct; 28(5):514-524. PubMed ID: 27825556
[TBL] [Abstract][Full Text] [Related]
5. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
6. Nutrients and the microenvironment to feed a T cell army.
Johnson MO; Siska PJ; Contreras DC; Rathmell JC
Semin Immunol; 2016 Oct; 28(5):505-513. PubMed ID: 27712958
[TBL] [Abstract][Full Text] [Related]
7. The effect of immunosuppressive molecules on T-cell metabolic reprogramming.
Fernández-Ramos AA; Poindessous V; Marchetti-Laurent C; Pallet N; Loriot MA
Biochimie; 2016 Aug; 127():23-36. PubMed ID: 27126071
[TBL] [Abstract][Full Text] [Related]
8. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac.
Vang AG; Housley W; Dong H; Basole C; Ben-Sasson SZ; Kream BE; Epstein PM; Clark RB; Brocke S
Biochem J; 2013 Dec; 456(3):463-73. PubMed ID: 24007532
[TBL] [Abstract][Full Text] [Related]
10. Cellular metabolism on T-cell development and function.
Chen H; Yang T; Zhu L; Zhao Y
Int Rev Immunol; 2015 Jan; 34(1):19-33. PubMed ID: 24708060
[TBL] [Abstract][Full Text] [Related]
11. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
Baeyens A; Saadoun D; Billiard F; Rouers A; Grégoire S; Zaragoza B; Grinberg-Bleyer Y; Marodon G; Piaggio E; Salomon BL
J Immunol; 2015 Feb; 194(3):999-1010. PubMed ID: 25548233
[TBL] [Abstract][Full Text] [Related]
12. Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Gerriets VA; Kishton RJ; Nichols AG; Macintyre AN; Inoue M; Ilkayeva O; Winter PS; Liu X; Priyadharshini B; Slawinska ME; Haeberli L; Huck C; Turka LA; Wood KC; Hale LP; Smith PA; Schneider MA; MacIver NJ; Locasale JW; Newgard CB; Shinohara ML; Rathmell JC
J Clin Invest; 2015 Jan; 125(1):194-207. PubMed ID: 25437876
[TBL] [Abstract][Full Text] [Related]
13. Metabolic regulation of immune responses: therapeutic opportunities.
Assmann N; Finlay DK
J Clin Invest; 2016 Jun; 126(6):2031-9. PubMed ID: 27249676
[TBL] [Abstract][Full Text] [Related]
14. Complex Interplay Between Metabolism and CD4
Yang J; Chen Y; Li X; Qin H; Bao J; Wang C; Dong X; Xu D
Cardiovasc Drugs Ther; 2023 May; ():. PubMed ID: 37199882
[TBL] [Abstract][Full Text] [Related]
15. Diverse Gene Expression in Human Regulatory T Cell Subsets Uncovers Connection between Regulatory T Cell Genes and Suppressive Function.
Hua J; Davis SP; Hill JA; Yamagata T
J Immunol; 2015 Oct; 195(8):3642-53. PubMed ID: 26371251
[TBL] [Abstract][Full Text] [Related]
16. mTOR and metabolic regulation of conventional and regulatory T cells.
Liu C; Chapman NM; Karmaus PW; Zeng H; Chi H
J Leukoc Biol; 2015 May; 97(5):837-847. PubMed ID: 25714803
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
[TBL] [Abstract][Full Text] [Related]
18. Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment.
Mockler MB; Conroy MJ; Lysaght J
Front Oncol; 2014; 4():107. PubMed ID: 24904823
[TBL] [Abstract][Full Text] [Related]
19. Harnessing Immune Cell Metabolism to Modulate Alloresponse in Transplantation.
Noble J; Macek Jilkova Z; Aspord C; Malvezzi P; Fribourg M; Riella LV; Cravedi P
Transpl Int; 2024; 37():12330. PubMed ID: 38567143
[TBL] [Abstract][Full Text] [Related]
20. Metabolic pathways in T cell fate and function.
Gerriets VA; Rathmell JC
Trends Immunol; 2012 Apr; 33(4):168-73. PubMed ID: 22342741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
